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microRNA expression in retinitis pigmentosa <p>MicroRNA expression profiling showed that the retina of mice carrying a rhodopsin mutation that leads to retinitis pigmentosa have  notably different microRNA profiles from wildtype mice; further in silico analyses identified potential retinal targets for differentially reg- ulated microRNAs.</p>
Abstract
Background:  The role played by microRNAs (miRs) as common regulators in physiologic
processes such as development and various disease states was recently highlighted. Retinitis
pigmentosa (RP) linked to RHO (which encodes rhodopsin) is the most frequent form of inherited
retinal degeneration that leads to blindness, for which there are no current therapies. Little is
known about the cellular mechanisms that connect mutations within RHO  to eventual
photoreceptor cell death by apoptosis.
Results: Global miR expression profiling using miR microarray technology and quantitative real-
time RT-PCR (qPCR) was performed in mouse retinas. RNA samples from retina of a mouse model
of RP carrying a mutant Pro347Ser RHO transgene and from wild-type retina, brain and a whole-
body representation (prepared by pooling total RNA from eight different mouse organs) exhibited
notably different miR profiles. Expression of retina-specific and recently described retinal miRs was
semi-quantitatively demonstrated in wild-type mouse retina. Alterations greater than twofold were
found in the expression of nine miRs in Pro347Ser as compared with wild-type retina (P < 0.05).
Expression of miR-1 and miR-133 decreased by more than 2.5-fold (P < 0.001), whereas expression
of miR-96 and miR-183 increased by more than 3-fold (P < 0.001) in Pro347Ser retinas, as validated
by qPCR. Potential retinal targets for these miRs were predicted in silico.
Conclusion: This is the first miR microarray study to focus on evaluating altered miR expression
in retinal disease. Additionally, novel retinal preference for miR-376a and miR-691 was identified.
The results obtained contribute toward elucidating the function of miRs in normal and diseased
retina. Modulation of expression of retinal miRs may represent a future therapeutic strategy for
retinopathies such as RP.
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Background
MicroRNAs (miRs) are small noncoding RNAs that regulate
gene expression at the post-transcriptional level in animals,
plants, and viruses [1,2]. Mature miRs are produced in two
steps after transcription of the primary miR transcript by
RNA polymerase II [3]. Nuclear cleavage of the primary miR
is mediated by Drosha and results in a short (about 75 nucleo-
tides) hairpin precursor miR [3]. Following active transport
to the cytoplasm by Ran and Exportin-5, the precursor miR is
further processed by Dicer [4]. The end product is a mature
miR (about 22 nucleotides) that, via incorporation into the
RNA-induced silencing complex [5], appears to play crucial
roles in eukaryotic gene regulation, primarily by post-tran-
scriptional silencing. The effect of the mature miR depends
largely on the level of base pairing with target sites, typically -
but not exclusively - located on the 3' untranslated region of
the mRNA [6,7]. Perfect or near perfect complementarity of
the miR to the target usually results in cleavage of the mRNA
[8,9], whereas imperfect base pairing leads to translational
repression by various mechanisms, including stalling transla-
tion, altering mRNA stability or moving mRNAs into specific,
translationally inactive cytoplasmic sites called 'P-bodies'
[1,10]. Additionally, RNA-directed transcriptional silencing
may guide interference at the nuclear DNA level by promoting
heterochromatin formation [1,10,11].
Recently, the role played by miRs in various ubiquitous bio-
logic processes, including developmental timing and pattern-
ing, left/right asymmetry, differentiation, proliferation
morphogenesis, and apoptosis, was highlighted [1,12-15]. For
example, in zebrafish embryo, intricate temporal and spatial
expression patterns of miRs support a role for them in verte-
brate development [16]. Aided significantly by progress in
miR microarray technology, sets of miRs have been found to
be highly or specifically expressed in various tissues, includ-
ing brain, in physiologic states [17-19]. Similarly, specific pat-
terns of miR expression profiles are emerging in disease
states, such as various forms of cancer [20,21], cardiac hyper-
trophy [22], and polyQ/tau-induced neurodegeneration [23].
A comprehensive description of mammalian miR expression
in different organ systems and cell types, including malignant
cells but excluding the retina, was recently constructed based
on small RNA library sequencing [24]. In relation to the eye,
miR-7 has been shown to play an important role in photo-
receptor differentiation in Drosophila [25] and other miRs,
such as miR-9, miR-96, miR-124a, miR-181, miR-182, and
miR-183, were found to be highly expressed during morpho-
genesis of the zebrafish eye [16]. In mouse, a number of miRs
(for instance, miR-181a, miR-182, miR-183 and miR-184)
were detected at high levels in various parts of the eye, includ-
ing the lens, cornea, and retina [26,27]. Most recently, using
microarray technology, 78 miRs were found to be expressed
in retina, including 12 miRs, whose expression varied diur-
nally [28]. However, despite the accumulating data, little is
known about the global miR expression profile of the mam-
malian retina in diseased states.
Retinitis pigmentosa (RP) is the most common form of inher-
ited retinal degeneration, affecting more than one million
individuals worldwide [29]. It is a debilitating eye disorder
that is characterized by progressive photoreceptor cell death
that eventually leads to blindness, for which no therapies are
currently available [30]. The fundamental genetic causes for
many forms of RP have been described; mutations in more
than 40 genes have been linked to the disease [31]. Notably,
mutations in the rhodopsin gene (RHO), which encodes a
principal protein of photoreceptor outer segments, are
responsible for approximately 25% of autosomal dominant
forms of RP [29,32]. Experimental data from animal models
of RP and human patients suggest that photoreceptors die
p r e m a t u r e l y  b y  a p o p t o s i s  [ 3 3 , 3 4 ] .  H o w e v e r ,  m u c h  l e s s  i s
known about the chain of events that leads from the different
mutations to eventual cell death, a process that can take dec-
ades in humans [35]. As mentioned above, altered miR
expression is believed to play a crucial role in various dis-
eases, including neuronal degeneration [23]. Similarly,
altered miR expression may underlie some of the mecha-
nisms that cause cellular dysfunction in RP, or indeed mech-
anisms that attempt to compensate for the disease
phenotype; to date, however, there is no experimental evi-
dence to support this hypothesis.
In the present study a miR expression profile in the mouse
retina was generated using miR microarray technology and
quantitative real-time RT-PCR (qPCR), and miRs with newly
assigned retinal preference were identified. Given the emerg-
ing role of miRs in health and disease, the retinal miR expres-
sion profiles of a mouse model of RP carrying a mutant
pro347ser RHO transgene (P347S) [36] and wild-type mice
were compared. Notably, the results from the study provide
the first evidence of modified miR expression profiles in reti-
nal disease.
Results
MicroRNA expression profile in wild-type retina
Retinal miR expression was initially evaluated using micro-
array analyses. Comparison of the retina versus brain sam-
ples (Figure 1a) or the retina versus mouse platform samples
(the latter prepared by pooling total RNA from eight different
mouse organs; Figure 1b) resulted in large differences in miR
expression profiles (Additional data file 1). Utilizing Exiqon
microarrays (Exiqon, Vedbaek, Denmark), 104 out of 224
probes between the retina versus brain and 152 out of 222
probes between the retina versus mouse platform exhibited
statistically significant (P < 0.05) differences in miR expres-
sion. More specifically, expression of 47 miRs in the retina
versus brain and 81 miRs in the retina versus mouse platform
changed by more than 2-fold (P < 0.05). In fact, the variance
in relative expression was in excess of ± 6 on a log2 scale (Fig-
ure 1a,b). Note that Exiqon's microarray contains 488 mouse
miR probes, but the probes that did not detect corresponding
miRs in the above RNA samples were omitted from the plots;http://genomebiology.com/2007/8/11/R248 Genome Biology 2007,     Volume 8, Issue 11, Article R248       Loscher et al. R248.3
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thus, the actual numbers of miRs included in Figure 1a and 1b
were 222 and 224, respectively.
Based on our miR microarray data, we undertook a semi-
quantitative comparison of relative expression levels of some
known retinal miRs (retinal specificity based on the work
reported by Karali [26] and Ryan [27] and their colleagues) in
retina, brain, and mouse platform (Figure 2a). Substantial
variations in miR relative expression levels between retina
and mouse platform were detected, ranging from a value of
more than 6 (for miR-183 and miR-96) down to about 1 (miR-
125a) on a log2 scale. Note, however, that these values are rel-
ative and therefore do not provide information about abso-
lute miR levels. For example, miR-125a has a similar level of
expression in retina, brain, and mouse platform, whereas
miR-183 exhibits remarkable specificity for retina. Relative
expression levels of additional miRs are given in Figure 2b, in
a similar manner to those given in Figure 2a. Differences
between relative miR expression levels in the retina versus
mouse platform of up to 4 on a log2 scale were detected (Fig-
ure 2b). For example, miR-9*, miR-335, miR-31, miR-106b,
miR-129-3p, miR-691, and miR-26b exhibited a relatively
high level of expression in the retina when compared with the
brain or the mouse platform. On the other hand, the relative
levels of miR-376a, miR-138, miR-338 and miR-136 were
high in the retina compared with the mouse platform, but
even higher in the brain. Let-7d was used as a control to indi-
cate ubiquitous miR expression in the retina, brain, and
mouse platform (Figure 2b).
Selected miRs depicted in Figure 2a,b were chosen, and their
relative expression levels quantified using qPCR in the retina,
brain, and mouse platform (Figure 2c). Notably, a close cor-
relation between qPCR and microarray data was found but,
because of the sensitivity of PCR, data from qPCR analysis
exhibited a higher dynamic range. For example, a difference
in miR-183 expression between retina and platform samples
was determined to be approximately 11 on a log2 scale by
qPCR, as compared with about 6 on a log2 scale by microarray
analysis. In case of miR-184 the disparity was more signifi-
cant, with corresponding log2  values of approximately 9
(qPCR) versus 2 (microarray). Transformation of the qPCR
log2 values into fold differences suggested that highly retinal
specific miRs (for instance, miR-183 and miR-96) are
expressed at more than a 1,000-fold greater degree in the ret-
ina than in the mouse platform. Recently described retinal
Volcano plots of miR expression in wild-type retina versus brain and mouse platform Figure 1
Volcano plots of miR expression in wild-type retina versus brain and mouse platform. Plots represent comparative miR expression profiles of (a) c57 
retina versus c57 brain and (b) c57 retina versus mouse platform using Exiqon miR microarrays. X-axis indicate difference in expression level on a log2 
scale, whereas the y-axis represents corresponding P values (Student's t-test) on a negative log scale; more lateral and higher points mean more extensive 
and statistically significant differences, respectively. Red lines indicate differences of ± 1, and significance level of P = 0.05. miR, microRNA.
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miRs, such as miR-129-3p, also exhibited remarkable prefer-
ence, with expressed being more than 250 times higher in the
retina than in the mouse platform (Figure 2c).
Expressions of miR-1, miR-9*, miR-26b, miR-96, miR-129-
3p, miR-133, miR-138, miR-181a, miR-182, miR-335 and
l e t 7 - d  w e r e  e x p l o r e d  b y  in situ hybridization (ISH) using
locked nucleic acid (LNA) probes (Exiqon). It is notable that
only the analysis of let-7, miR-181a, and miR-182 produced
detectable signals (Figure 3). Let-7 was expressed uniformly
in the inner nuclear layer (INL) and labeling was also appar-
ent in the ganglion cell layer (Figure 3a). MiR-181a was
strongest in expression among these three miRs and was
detected in the inner part of the INL, probably corresponding
to amacrine cells and in the ganglion cell layer (Figure 3b).
MiR-182 was expressed in the photoreceptor cells in the outer
nuclear layer (ONL, Figure 3c). Both let-7 and miR-181a were
mainly localized in the nuclear layers (Figure 3a,b), in con-
trast, miR-182 labeling was weaker in the ONL (cell bodies)
but was strongly localized in the photoreceptor inner seg-
ments and between the ONL and INL, possibly in photo-
receptor synapses (Figure 3c,d). Additionally, miR-182
labeling was also observed in the outer part of the INL. Labe-
ling patterns depicted by ISH indicate cell type specific
expression and possible differential intracellular targeting of
t h e s e  m i R s ,  n a m e l y  t o  t h e  c e l l  b o d y  o r ,  i n  c a s e  o f  p h o t o -
receptor cells, to the photoreceptor inner segments and
synapse.
Altered miR expression in P347S retina
Given the emerging roles played by miRs in various diseases,
we hypothesized that perturbed miR expression might con-
tribute to some of the cellular events that underlie the pathol-
ogy observed in RP. To seek experimental evidence to support
this theory, miR expression profiles in retinas from an RP
transgenic mouse model (P347S) [36] and c57 and 129 wild-
t y p e  m i c e  w e r e  c o m p a r e d  b y  m i c r o a r r a y  a n a l y s e s  ( F i g u r e
4a,b,c and Additional data files 1 and 2). To reflect the adult
miR expression pattern and to allow valid comparison of ret-
inas from P347S and wild-type mice (the former with a pro-
gressive retinal degeneration and associated photoreceptor
cell loss [36]), animals at age 1 month were chosen for the
study. Figure 5 illustrates representative retinal histology of
P347S (Figure 5a) versus wild-type c57 mice (Figure 5b) at 1
month of age. Compromised photoreceptor outer segments
and a slightly decreased thickness of ONL (by ≤25%) were
apparent in P347S mice (Figure 4a) when compared with
wild-type control animals (Figure 5b). As a result, alterations
in the retinal miR profile should be similar in magnitude to
that of photoreceptor cell loss (approximately ± 25%). In con-
trast, larger changes in intracellular miR levels should reflect
changes that have occurred because of altered regulation of
miR expression in the P347S mutant retina. A 2-fold change
threshold was set (+100% and -50%) to screen for miRs that
differed in expression between P347S and wild-type mice.
In order to account for the mixed c57/129 genetic background
of P347S mice, miR expression profiles in the retinas of P347S
mice were compared with those in both c57 (Figure 4b) and
129 wild-type mice (Figure 4c); additionally, miR expression
Comparative expression of selected miRs in the retina, brain, and mouse  platform Figure 2
Comparative expression of selected miRs in the retina, brain, and mouse 
platform. Bars represent deviations from mean expression levels for each 
microRNA (miR) on a log2 scale in c57 retina (dark blue), c57 brain (light 
blue), and mouse platform (magenta). (a) Relative expression of some 
known retinal miRs. (b) Relative expression of miRs with novel retinal 
specificity. Panels a and b display data from miR microarray experiments. 
(c) Quantitative real-time reverse transcription polymerase chain reaction 
(qPCR) validation of expression of selected miRs. Note that columns are 
in descending order of difference between retinal and platform expression; 
y-axes are to different scales; and bars for miR-181a in brain and miR-204 
in mouse platform are missing in panel a because of incomplete data.
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profiles of wild-type c57 versus 129 strains were directly com-
pared (Figure 4a and Additional data file 2). In the c57 versus
129 comparison, minor variations in miR expression profiles
were detected; out of 640 probes on the Ambion microarray,
25 gave significant (P < 0.05) but lower than 2-fold deviations
between the two strains (Figure 4a). In contrast, the P347S
versus c57 retina (Figure 4b) and the P347S versus 129 retina
(Figure 4c) plots demonstrated marked alterations between
the P347S and wild-type mouse miR profiles. Figure 4 parts b
and c are almost identical and reveal statistically significant
(P < 0.05) changes of 63 and 75 out of 640 miRs respectively,
with only eight and nine miRs exhibiting greater than 2-fold
(P < 0.05) changes between the P347S and wild-type c57 or
129 mouse retinal miR expression profiles. Using Exiqon
LNA microarray technology, 16 probes had greater than 2-
fold alterations (P < 0.05) between the P347S and c57 miR
miR ISH analysis in the mouse retina Figure 3
miR ISH analysis in the mouse retina. Eyes from 1-month-old c57 animals were fixed in 4% paraformaldehyde, and 12 μm cryosections were in situ 
hybridized with 5'-digoxigenin labeled locked nucleic acid (LNA) microRNA (miR) probes for (a) let-7, (b) miR-181a, and (c,d) miR-182. A false-colored 
(magenta) 4',6-diamidine-2-phenylindole-dihydrochloride (DAPI) nuclear staining is overlaid on the miR-182 in situ hybridization (ISH) label (panel d) to 
indicate the position of the nuclear layers. Scale bar: 25 μm. GCL, ganglion cell layer; INL, inner nuclear layer; IS, photoreceptor inner segments; ONL, 
outer nuclear layer; OS, photoreceptor outer segments.
Volcano plots of miR expression in P347S and wild-type retinas Figure 4
Volcano plots of miR expression in P347S and wild-type retinas. Plots represent comparative microRNA (miR) expression profiles of (a) c57 versus 129 
retinas, (b) c57 versus P347S (mutant pro347ser RHO transgene) retinas, and (c) 129 versus P347S retinas using Ambion miR microarrays. X-axis indicate 
difference of expression level on a log2 scale, while y-axis represents corresponding P values (Student's t-test) on a negative log scale; more lateral and 
higher points mean more extensive and statistically significant differences, respectively. Red lines indicate differences of ± 1 and significance level of P = 
0.05. Labels are given for miRs with changes of higher than ± 1 (P < 0.05). MiR-1, miR-96, miR-133, and miR-183 are highlighted in red; h and m in labels 
refer to human and mouse miRs.
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profiles (Additional data file 1). Note that for a number of
miRs (for example, miR-1, miR-133, and miR-96), both
Ambion and Exiqon microarrays detected similar alterations
in expression between the P347S mutant and wild-type
retinas.
For qPCR validation, miRs with greater than 2-fold differ-
ences (P < 0.05) in expression between the P347S and wild-
type mice were selected. Further criteria were that their signal
values were above background for all samples and replicates,
and probes corresponded to valid entries in the Sanger miR
Database [37,38]. The above conditions were met by miR-1,
miR-96, miR-133, and miR-183 (highlighted in red in Figure
4b,c); these miRs were therefore selected for qPCR quantifi-
cation. Note, that in case of miR-96 greater than a 2-fold dif-
ference (P  < 0.05) between the P347S and c57 mice was
obtained with Exiqon microarrays only (Additional data file
1), while values from Ambion microarray analysis fell just
below threshold. Some probes with greater than 2-fold
changes (P  < 0.05) represented unspecified Ambion or
Exiqon miR sequences and thus were excluded from qPCR
validation. Figure 6 displays corresponding data from the two
different microarrays and qPCR analyses for miR-96, miR-
183, miR-1, and miR-133. In general, a good correlation
among data from qPCR and the two microarrays was found,
with the exception of miR-183, for which the Exiqon micro-
array did not pick up the differential expression between
mutant and wild-type retinas that was observed by qPCR
(Figure 6). In summary, expression of miR-96 and miR-183
decreased by more than 2.5-fold (P < 0.001) in mutant reti-
nas, whereas miR-1 and miR-133 increased by more than 3-
fold (P < 0.001), as measured using qPCR. These results pro-
vide the first evidence for an altered miR expression profile in
retinal disease.
Comparative histology of 1-month-old c57 and P347S retinas Figure 5
Comparative histology of 1-month-old c57 and P347S retinas. Eyes from 
1-month-old c57 and P347S (mutant pro347ser RHO transgene) animals 
were fixed in 4% paraformaldehyde, 12 μm cryosections cut, and nuclei 
counterstained with 4',6-diamidine-2-phenylindole-dihydrochloride 
(DAPI). Phase contrast and fluorescent dark field (DAPI, false colored) 
microscopic images were overlaid to display histology of (a) P347S and 
(b) c57 retinas. Combined thicknesses of photoreceptor outer an inner 
segments (yellow arrows) and outer nuclear layer (magenta arrows) are 
indicated. Scale bar: 25 μm. GCL, ganglion cell layer; INL, inner nuclear 
layer; IS, photoreceptor inner segments; ONL, outer nuclear layer; OS, 
photoreceptor outer segments.
Differentially expressed miRs between c57 versus P347S retinas Figure 6
Differentially expressed miRs between c57 versus P347S retinas. 
Expressions of mouse microRNA (miR)-96, miR-183, miR-133 and miR-1 
were analyzed using Ambion miR microarrays (green, 'A-' in legend), 
Exiqon miR microarrays (blue, 'E-' in legend), and quantitative real-time 
reverse transcription polymerase chain reaction (qPCR; magenta). 
Expression levels of each miR in P347S (mutant pro347ser RHO transgene; 
dark green, dark blue, and purple columns) versus c57 retinas (taken as 
100%; light green, light blue and magenta columns) were compared. Note 
that the y-axis is discontinuous. *P < 0.05, **P < 0.01, and ***P < 0.001.
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Table 1
Overview of retinal miR target hits predicted by miRanda
Label miRanda total hits miRanda target genes miRanda targets present in retinal 
libraries and lists
miR-96 994 857 518
miR-183 1064 902 541
miR-1 921 760 446
miR-133 1,097 925 592
miR, microRNA.http://genomebiology.com/2007/8/11/R248 Genome Biology 2007,     Volume 8, Issue 11, Article R248       Loscher et al. R248.7
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Potential target transcripts for miR-96, miR-183, miR-1 and
miR-133 predicted by miRanda [39] were retrieved from the
Sanger miR Database [37]. In order to select for targets
expressed in the retina, the transcripts were screened against
seven Unigene mouse retina libraries and three gene lists
derived from NEIBank [40] and serial analysis of gene
expression (SAGE) studies in the mouse retina [41,42].
Matches based on gene names were extracted, resulting in a
final subset of 1,664 miRanda predicted transcripts that are
associated with known genes and are present in at least one
retinal library or gene list (Table 1). The resulting miR targets
were sorted by miRanda score, P orthologous group value,
presence in the seven retinal libraries and three eye related
lists (a score of 1 to 10), and predicted miR target sites per
transcript (1 to 3). Additional data file 3 lists potential retinal
target transcripts with the highest rankings for miR-96, miR-
183, miR-1, and miR-133. Notably, transcripts of retinal dis-
ease genes, such as Crb1  (encoding Crumbs homolog 1),
Abca4 (subfamily-D ATP-binding cassette member 4), Pde6a
(phosphodiesterase 6A), Prpf8 (pre-mRNA processing factor
8) and Prpf31  (pre-mRNA processing factor 31 homolog),
together with an additional 48 eye disease genes, are pre-
dicted to be targeted by these miRs (Additional data file 3). A
subset of highly ranked potential targets for miR-96, miR-
183, miR-1 and miR-133 are implicated in the visual cycle (for
example Abca4, Pitpnm1 [membrane associated phosphati-
dylinositol 1], and Pde6a), in cytoskeletal polarization (for
example, Crb1 and Clasp2 [CLIP associating protein 2]), and
in transmembrane and intracellular signaling (for example,
Clcn3  [chloride channel 3], Grina  [N-methyl-D-aspartate-
associated glutamate receptor protein 1], Gnb1  [guanine
nucleotide binding protein beta 1 polypeptide] and Gnb2
[guanine nucleotide binding protein beta 2 polypeptide]).
Notably, predicted targets of miR-96 and miR-183 also
include apoptosis regulators, such as Pdcd6  (programmed
cell death 6) and Psen2 (presenilin 2) and transcription fac-
tors (for example, Asb6 [ankyrin repeat and SOCS box-con-
taining protein 6] and Ndn  [Necdin]). Additionally, target
transcripts for miR-1 and miR-133 comprise mRNA process-
ing factors (for example, Syf11 [SYF2 homolog RNA splicing
factor], Prpf8, and Hnrpl [heterogeneous nuclear ribonucle-
oprotein L]), an apoptosis inhibitor (Faim  [Fas apoptotic
inhibitory molecule]), and proteins that are involved in intra-
cellular trafficking and motility (for example, Ktn1 [Kinectin
1]), Actr10 [ARP10 actin related protein 10 homolog], and
Myh9 [non-muscle myosin heavy chain polypeptide 9]; see
Additional data file 3).
In summary, it has been demonstrated that miR expression in
retinas from two wild-type mouse strains are very similar,
and in contrast different patterns of expression between the
retina, brain, and mouse platform were determined by miR
microarray profiling. The results of the study suggest that the
relative magnitude in expression of widely accepted retinal
miRs varies remarkably in retina. Furthermore, the preferen-
tial expression in the retina of additional miRs, such as miR-
376a and miR-691, represents a novel discovery. Retinal ISH
analysis suggested cell type specific and intracellularly local-
ized expression for the detected miRs. A comparative analysis
between P347S and wild-type mouse retinas revealed a signif-
icant alteration in miR expression profiles in mutant mice, as
evaluated by microarray analysis and validated by qPCR.
More specifically, significant differences in expression of
miR-1, miR-96, miR-133, and miR-183 in retina were
observed between RHO mutant and wild-type mice. Potential
retinal target transcripts for these miRs included, among oth-
ers, genes implicated in retinal diseases and genes encoding
components that are involved in apoptosis and intracellular
trafficking.
Discussion
A global expression profile of miRs currently available on
microarrays was determined in mouse retina using two differ-
ent microarray chemistries. Additionally, retinal preference/
specificity was determined for miR-9*, miR-335, miR-31,
miR-106, miR-129-3p, miR-691 and miR-26b by microarray
analysis, and expression levels of miR-129-3p, miR-335 and
miR-31 were also validated using qPCR. During the review
process for this manuscript, Xu and coworkers [28] also
reported retinal expression for some of these miRNAs. Little
is known about the expression pattern, targets, or roles of
these miRNAs. MiR-9* has previously been described as miR-
131 [18], but it appears to be the sense strand of all three miR-
9 predicted stem-loops. MiR-335 has been shown to be
expressed in lung [43], miR-31 in colon [20], and miR-106 in
megakaryocytes [44]. MiR-26b expression has been detected
in mouse cortex and cerebellum [18], and more recently in
embryonic stem cells [45], neuronal cells [46], and pancreatic
cells [47]. MiR-129-3p was first cloned using a mouse pancre-
atic beta-cell line [47], whereas miR-691 was cloned from
mouse embryo [48]. The roles of these miRs in the various
tissues where they were originally isolated, or in retina, are
largely unknown. Preferential expression in the retina was
also observed for miR-376a, miR-138, miR-338, and miR-136
as compared with the mouse platform; it is notable, however,
that these miRs are expressed at higher levels in brain than in
retina. Indeed miR-136, miR-138, and miR-338 were previ-
ously cloned from the hippocampus and cerebral cortex [19].
Previously, miR-9, miR-29c, miR-96, miR-124a, miR-181a,
miR-182, miR-183, and miR-204 were localized in the mouse
retina by ISH [26-28]. However, ISH detection of other ret-
ina-specific miRs, including miR-213, miR-216, and miR-217,
was unsuccessful in retina [26,27]. Among the 11 ISH probes
investigated in the current study, only three (let-7, miR-181a,
and miR-182) resulted in positive labeling in retina. Never-
theless, these three miRs exhibited an intricate pattern of
expression, suggesting marked cell type specificity and also
differential intracellular targeting. The most probable reason
for the unsuccessful ISH detection of the other miRs tested is
lower expression in terms of absolute quantities; other fac-Genome Biology 2007, 8:R248
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tors, such as secondary structure of probe or target, might
also have contributed. Regarding photoreceptor specific
expression, miR-182 has been shown to be strongly and
exclusively expressed in rod photoreceptors [26], although
the results of the present study also indicate labeling in the
outermost part of the INL. This is in accordance with recent
findings reported by Xu and coworkers [28], who demon-
strated that expression of miR-96, miR-182, and miR-183
was not exclusive to photoreceptor cells in 4-month-old reti-
nal degenerative 1 mice (rd1 [49]). Additionally, mir-124a
expression is strong in photoreceptor outer segments and
inner segment in adult mouse retina [26]. Marked retinal spe-
cificity of these miRs was verified by the microarray and
qPCR analyses undertaken in the present study. The results
obtained also indicate that although miR-124 and miR-9* are
highly expressed in the retina as compared with the mouse
platform, they are also expressed in the brain at a similar
level. In fact, miR-124 and miR-9* are also known to be brain
specific miRs [19,50,51].
In order to gain better insight into the possible association
between miRs expression and retinal degeneration in dis-
eases such as RP, retinal miR expression profiles of P347S
versus wild-type mice were compared. Among others, expres-
sion of miR-96, miR-183, miR-1, and miR-133 exhibited sig-
nificant alterations in P347S mice by microarray analysis, and
these changes were validated by qPCR. The expression of
miR-96 and miR-183 was reduced by more than 2.5-fold in
P347S retinas compared with wild-type mouse retinas. The
similar alteration in expression levels of these miRs may
potentially be due to their close linkage (within 4 kilobases)
on mouse chromosome 6qA3, thereby indicating that they
may be co-regulated [38]. Indeed, recent studies in retina
[28,42], inner ear [52], and dorsal root ganglia [53] suggest
that miR-183, miR-96 and miR-182 may represent a con-
served sensory organ-specific cluster of miRs, and that these
miRs may potentially be under similar transcriptional con-
trol. In contrast, miR-1 and miR-133 levels increased by more
than 3-fold in retinas of P347S mice. These miRs are also
likely to be co-regulated [31] and have been described in rela-
tion to cardiac disease [22] and skeletal muscle proliferation
and differentiation [54]. Interestingly, expression of miR-1
and miR-133 were found to be decreased in cardiac hypertro-
phy, whereas their over-expression inhibited hallmarks of
induced cardiac hypertrophy in vitro and in vivo [22]. Simi-
larly, the observed increased expression of miR-1 and miR-
133 in the P347S retina may possibly suggest that a compen-
satory mechanism has been activated in the mutant retina in
an attempt to prevent photoreceptor cell death.
Using a bioinformatics approach, potential target genes for
miR-96, miR-183, miR-1, and miR-133 were predicted and
screened against genes expressed in the mouse retina [41,42]
and 488 genes linked with eye diseases [40]. The top 50 can-
didate target transcripts corresponded to genes that are,
among others, involved in the visual cycle and transmem-
brane and intracellular signaling, and a number of retinal dis-
ease genes. Because expression of miR-96 and miR-183 is
decreased, corresponding targets may potentially be upregu-
lated in P347S mice. Notably, apoptosis and transcription fac-
tor genes are among the predicted targets for miR-96 and
miR-183. In contrast, as miR-1 and miR-133 are upregulated,
expression of their targets may possibly be suppressed in
P347S mice. Many genes encoding factors that are involved in
mRNA processing and splicing, and RNA-binding proteins
belong to the predicted targets for miR-1 and miR-133. Addi-
tionally, genes encoding cytoskeletal and intracellular
transport proteins, as well as an apoptosis inhibitor, were also
predicted to be targets for these two miRs. These findings are
in accordance with the suggestion that defective vectorial
transport of rhodopsin in photoreceptor cells may be a possi-
ble precursor to cell death in P347S mice [36]. Potential acti-
vation of apoptosis genes and suppression of an apoptosis
inhibitor is also in good agreement with the apoptotic death
of photoreceptor cells observed in P347S retina, indeed
emphasizing the role played by miRs in apoptosis [15]. MiR
target transcript predictions, such as those made in the
present study, are useful in highlighting the possible miR-
dependent regulatory mechanisms that underlie retinal
degeneration in P347S mice. However, further studies and
experimental evidence is required to validate the predicted
miR target transcripts.
Not all miRs with greater than 2-fold changes in expression
between P347S and wild-type mice were followed up for
qPCR validation. Unspecified Ambion and Exiqon company
sequences, which are not as yet entered into the Sanger miR
Database [37], were excluded from analysis but are listed in
Additional data files 1 and 2. Other miRs, such as miR-451
and miR-146a (from Ambion microarray data) or miR-21,
miR-23 and miR-140 (from Exiqon microarray data) were
also left out from further analysis because these miRs
exhibited very low levels of expression in the retina compared
with the mouse platform. It was deemed that low signal-to-
background ratios might have interfered with detection of the
genuine expression levels for these miRs. The screening crite-
rion implemented in the study (the threshold of at least a 2-
fold change between P347S and wild-type mouse retinas) was
chosen arbitrarily. It is notable that expression of more than
50 miRs changed significantly but by less than 2-fold (Figure
4 and Additional data files 1 and 2). Many of these may repre-
sent miRs whose intracellular expression might also have
genuinely been altered in P347S retinas.
In the present study, the P347S transgenic model was selected
for two reasons. RHO-linked RP is one of the most common
types of RP, representing approximately 25% of all autosomal
dominantly inherited RP cases in human patients [32]. In
principle, the P347S transgenic animal model therefore
potentially mirrors cellular events of a very frequent form of
human RP. In addition, P347S mice are very useful because
the retinal degeneration in this mouse model is relatively slowhttp://genomebiology.com/2007/8/11/R248 Genome Biology 2007,     Volume 8, Issue 11, Article R248       Loscher et al. R248.9
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[36] compared with that in other RHO-linked transgenic RP
lines, such as the Pro23His RHO mouse [55]. Slow degenera-
tion in P347S mice provides a reasonable time frame for the
mutant retina to develop into adulthood while maintaining a
relatively normal histological structure and function, the lat-
ter demonstrated by normal electroretinography [36]. In
particular, a time point of 1 month of age was chosen for the
analysis because at this age P347S mice have a fully differen-
tiated retina; in addition, although P347S mice carry a RHO-
linked RP mutation with corresponding cellular dysfunctions,
these mice exhibit only a minor decrease in photoreceptor cell
numbers.
Note that in the present study a somewhat more significant
degeneration in the P347S animals was detected compared
with the original findings [36], which indicated little or no
photoreceptor cell loss at this age. Regarding potential alter-
ations in expression of individual miRs due to the above
changes in cell composition in the P347S retina, they should
in principle mirror the percentage of photoreceptor cell loss
(approximately ± 25%). In light of this, it is unlikely that the
significant changes observed in the expression of miR-96,
miR-183, miR-1 and miR-133 are due to the altered cellular
composition of the P347S retina. In contrast, Xu and cowork-
ers [28] used rd1 mice with severe retinal degeneration to
demonstrate retinal expression of miR-96, miR-182, and
miR-183 in cells other than photoreceptor cells. In this case,
altered expression of these miRs between wild-type and
mutant retina was observed most likely because of the signif-
icant shift in cellular constituents (complete loss of photore-
ceptors) in the rd1 retina. It is also worth noting that the
P347S mice are on a c57/129 mixed genetic background. The
almost identical miR profiles between c57 versus 129 mice
and the similar profiles between c57 versus P347S mice and
129 versus P347S mice support the view that the differences
observed in retinal miR expression profiles, between P347S
and wild-type mice, are a function of the presence of the RHO
mutation in P347S mice and are not due to differences in
genetic background.
Conclusion
Data from this study combined with previous results demon-
strate a widespread and intricate expression of miRs in the
wild-type mouse retina. A small subset of miRs exhibits a high
degree of tissue specificity, whereas others appear to be more
ubiquitously expressed; there is a particular overlap between
miRs expressed to relatively high degrees in retina and brain.
Notably, potential function of miRs in retinal disease is high-
lighted by the first demonstration of an altered miR expres-
sion profile in retinal degeneration. Using a transgenic mouse
model of a common form of human RP, widespread changes
in miR expression profile were detected. In particular, the
expression of two retinal specific miRs decreased signifi-
cantly, whereas two non-retina-specific miRs, with a known
role in muscle differentiation, proliferation and disease,
increased extensively. Data presented in this study also con-
tribute toward our understanding of the role played by miRs
in the mouse retina by comparative miR expression profiling.
From this analysis, a number of miRs were highlighted with
newly identified retinal preference. At present, knowledge of
the function of miRs in development, normal physiology, or
disease states of the retina is limited. Notably, results from
this study suggest that in RHO-linked RP the miR expression
profile has been altered, mirroring observations in other dis-
ease states. Further studies should reveal the network of
corresponding cellular targets and underlying mechanisms.
Identifying disease-related miRs in RP models may provide a
better understanding of the pathophysiology of retinal
degeneration. Additionally, modulation of the expression of
key miRs may potentially open future avenues for therapeutic
development for retinopathies such as RP, in which - despite
significant effort - there are currently no therapies.
Materials and methods
Experimental animals and RNA isolation
Transgenic P347S [36] and wild-type 129 and c57 mouse
strains were used in these experiments. P347S animals are on
a mixed c57/129 genetic background and carry a Pro347Ser
mutation in the carboxyl terminal of RHO; this mutation has
been identified in some autosomal dominant RP families
[32]. To compensate for the extra RHO transgene, these mice
were maintained on a mouse rhodopsin +/- background
(Rho+/-) [30], resulting in a P347+/-Rho+/- genotype. Retinal
degeneration in these animals is slower than in most other RP
models, with little or no photoreceptor cell loss at age 1 month
and 50% of photoreceptors remaining at 4 to 5 months of age
[36]. The spatial expression of RHO  is normal and elec-
troretinography amplitudes are comparable to that in the
wild-type animals at 1 month of age [36]. Mice were main-
tained under specific pathogen free housing conditions.
Animal welfare complied with the Association for Research in
Vision and Ophthalmology statement for the Use of Animals
in Ophthalmic and Vision Research and the European Com-
munities Regulations 2002 and 2005 (Cruelty to Animals
Act). At 1 month of age mice were killed by carbon dioxide
asphyxiation.
For in situ hybridization studies, eyes from four animals from
each strain were dissected and fixed in 4% paraformaldehyde
for 4 hours at 4°C. For total RNA isolation retinas and brains
were dissected immediately and extracted using the mir-
Vana™ RNA Isolation kit (Ambion Inc., Austin, TX, USA), in
accordance with the manufacturer's procedure. Tissue sam-
ples for total RNA were obtained in triplicate. In each sample
six retinas were pooled, whereas individual brains were fro-
zen in liquid nitrogen and homogenized over dry ice; 50 to
100 μg of the resulting powder was used for extraction. In
order to represent the mouse body, a mouse total RNA
platform was prepared by pooling total RNA from eight dif-
ferent mouse organs (liver, thymus, heart, lung, spleen, testi-Genome Biology 2007, 8:R248
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cle, ovary, and kidney) from the Mouse Assorted Total RNA
kit (Ambion Inc.).
Microarray experiments
Two different miR microarray technologies (mirVana™
miRNA Bioarray [Ambion Inc.] and miRCURY™ LNA miR
Array [Exiqon, Vedbaek, Denmark]) were used. The mirVana
technology is single-colored and profiles 640 human, mouse,
and rat miRs (including 154 Ambion miRs) using amine-
modified DNA probes. The miRCURY microarray is dual-
colored (to accommodate parallel hybridization of a reference
sample) and contains LNA probes for 342 mouse and 146
Exiqon miRs. Note, that the Ambion and Exiqon company
miRs are not entered into the Sanger miR Database [37].
P347S, 129 and c57 retinal samples were outsourced to
Ambion Inc., and P347S retinal, c57 retinal, c57 brain and
mouse platform samples were outsourced to Exiqon for miR
profiling. All samples and replicates were analyzed on sepa-
rate miR microarrays.
mirVana miR microarray analysis
The mirVana miRNA Labeling Kit (Ambion Inc.) was used to
label the samples with Cy5. The labeled samples were
denatured and hybridized to the array for 12 to 16 hours at
42°C. Low stringency washes were followed by a high strin-
gency wash to remove nonspecific binding to the array
probes. The arrays were dried and images were acquired
using the Axon® GenePix 4000B scanner and GenePix soft-
ware (Molecular Devices Ltd., Wokingham, UK). The raw sig-
nal for each probe was obtained by subtracting the maximum
of the local background and negative control signals from the
foreground signal. The data was pre-processed to remove
poor-quality spots and normalization was used to remove any
systematic bias. Global normalization of the microarrays was
undertaken using the variance stabilization normalization
[56] method. The resulting generalized log2 values were used
in further data analysis.
miRCURY LNA miR microarray analysis
Using the miRCURY™ LNA miR Array Labeling kit (Exiqon),
experimental samples and a reference sample were labeled in
separate reactions with Hy3 and Hy5, respectively. Labeled
experimental and the reference sample were combined, dena-
tured, and hybridized to microarrays at 65°C for 16 to 18
hours. Low stringency and high stringency washes were car-
ried out and the microarrays dried. Images were acquired
using the Axon® GenePix 4000B scanner and GenePix soft-
ware. The data was pre-processed and normalized using the
global locally weighted scatterplot smoothing procedure [57].
Normalized log2-transformed Hy3/Hy5 ratios were used for
further analysis.
Data availability
Microarray data from the above studies are available at the
public database Array Express [58] using the following acces-
sion numbers: E-TABM-329 (miRNA expression in diseased
mouse retina) and E-TABM-332 (comparative miRNA profile
of retina, brain, and RP).
Quantitative real-time RT-PCR
Two-step qPCR was performed using ABI's TaqMan miR
Assay (Applied Biosystems, Foster City, CA, USA), in accord-
ance with the manufacturer's recommendations. Briefly, 10
ng total RNA was reverse transcribed with miR specific prim-
ers in 15 μl reaction volumes. Reverse transcription reactions
were diluted 60-fold and 5 μl was amplified in triplicates by
TaqMan qPCR on a 7300 Real Time PCR System (Applied
Biosystems); quantification was performed utilizing the com-
parative Ct method [59]. RNU19 was employed as an internal
control; log2-transformed miR/RNU19 expression ratios
were used for further analysis.
miR in situ hybridization and microscopy
5'-Digoxigenin (DIG) labeled, LNA-modified oligonucleotide
ISH probes were purchased from Exiqon for the following
mouse miRs: 1, 9*, 26b, 96, 129-3p, 133, 138, 181a, 182 and
335, and let-7d (including sense-159) as background control.
Paraformaldehyde-fixed eyes were cryoprotected, cryosec-
tioned (12 μm), thaw-mounted onto 3-aminopropyltriethox-
ysilane-coated microscope slides, and stored at -20°C.
Sections were post-fixed in 4% paraformaldehyde and treated
with diethyl-pyrocarbonate before a 2-hour pre-hybridization
step in hybridization solution (50% formamide, 5 × sodium
chloride/sodium citrate [SSC; pH 6.0], 0.1% Tween, 50 μg/ml
heparin, and 500 mg/ml yeast tRNA). Sections were hybrid-
ized with LNA probes at 20 nmol/l concentration at the melt-
ing temperature (Tm) minus 21°C in a humidified chamber
for 16 to 18 hours. Hybridized sections were then washed with
50% formamide and 2 × SSC at the hybridization tempera-
ture. Following 1 hour of blocking in 2% sheep serum, 2 mg/
ml bovine serum albumin in phosphate-buffered saline (PBS)
with 0.1% Tween, the slides were incubated with anti-DIG/
alkaline phosphatase antibody/enzyme conjugate (1:2,000;
Roche Diagnostics Ltd, Burgess Hill, UK) overnight at 4°C.
Following successive washes in PBS with 0.1% Tween, the
sections were incubated with nitroblue tetrazolium and 5-
bromo-4-chloro-3-indoyl phosphate substrate (NBT-BCIP;
Roche) for up to 48 hours. The reaction was stopped by
washes in PBS, nuclei were counterstained with 4',6-diami-
dine-2-phenylindole-dihydrochloride. Sections were ana-
lyzed by bright field normal and phase-contrast as well as
fluorescent microscopy using an Axiophot microscope (Carl
Zeiss Ltd, Hertfordshire, UK). Corresponding images were
overlaid in Adobe Photoshop (Adobe Systems Europe Ltd,
Glasgow, UK).
Bioinformatics
Potential retina specific targets of miR-1, miR-96, miR-133,
and miR-183 were generated through computational means.
Mouse transcripts predicted to be microRNA targets were
retrieved from the Sanger microRNA Database [37]. Predic-
tions were computed using microRNAanda version 3 [39] andhttp://genomebiology.com/2007/8/11/R248 Genome Biology 2007,     Volume 8, Issue 11, Article R248       Loscher et al. R248.11
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filtered for P orthologous group value < 0.05. IDs of genes
expressed in retina were downloaded from seven selected
mouse eye libraries in UniGene (build #164) as follows:
Lib.8659, NIH_MGC_94 (23,422 expressed sequence tags
[ESTs] grouped into 7,638 UniGene entries); Lib.6780,
NIH_BMAP_Ret4_S2 (19,072 ESTs grouped into 8,437
UniGene entries); Lib.5390, RIKEN full-length enriched,
a d u l t  r e t i n a  ( 6 , 0 8 9  E S T s  g r o u p e d  i n t o  3 , 4 5 2  U n i G e n e
entries); Lib.15224, mouse retina, unamplified: mk/ml
(4,658 ESTs grouped into 2,832 UniGene entries);
Lib.20873, mouse retina, Y2H (nbk) (1,843 ESTs grouped
into 1290 UniGene entries); Lib.12980, mouse adult retina
(1,111 ESTs grouped into 872 UniGene entries); and Lib.6773,
NIH_BMAP_Ret3 (961 ESTs grouped into 748 UniGene
entries).
Additionally, genes were retrieved from two SAGE studies
that determined genes expressed in the mouse retina and
from an eye disease gene list at NEIBank [40] translated into
mouse homologs: 3,516 UniGenes (with tag-level > 3) from
Blackshaw and coworkers [41]; 3,475 UniGenes from Black-
shaw and coworkers [42]; and mouse homologs of 488 eye
disease genes from NEIBank [40].
Ensembl transcripts from microRNAanda prediction and
UniGene entries from mouse retina libraries and lists were
linked and extracted whenever gene names were available in
both sources.
Statistical analysis
Data from given sets were pooled and averaged, and standard
deviation values calculated. Statistical significance of differ-
ences between datasets were determined using either Stu-
dent's two-tailed t-test or analysis of variance; differences
with P < 0.05 were considered statistically significant.
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DIG, digoxigenin; EST, expressed sequence tag; INL, inner
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RP, retinitis pigmentosa; RT-PCR, reverse transcription
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a table listing
retinal miR expression data from Exiqon microarray analysis.
Additional data file 2 is a table listing retinal miR expression
data from Ambion microarray analysis. Additional data file 3
is a table listing highly ranked retinal miR target genes pre-
dicted using miRanda.
The miRNA array data are available at Array Express [58]
using accession numbers E-TABM-329 and E-TABM-332.
Additional data file 1 Retinal miR expression data from Exiqon microarray analysis Log2 median ratios are given for c57, 129, and P347S retinas at age  1 month; analysis was carried out in triplicate. P values by Student's  t-test are also provided. Click here for file Additional data file 2 Retinal miR expression data from Ambion microarray analysis Global normalised log2 ratios are given for c57, 129, and P347S ret- inas at age 1 month; analysis was carried out in triplicate. P values  by analysis of variance and Student's t-test are also provided. Click here for file Additional data file 3 Highly ranked retinal miR target genes predicted using miRanda Presented is a table listing highly ranked retinal miR target genes  predicted using miRanda. Click here for file
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